Bill C-10

An Act respecting certain measures related to COVID-19

This enactment authorizes the Minister of Health to make payments of up to $2.5 billion out of the Consolidated Revenue Fund in relation to coronavirus disease 2019 (COVID-19) tests.
It also authorizes that Minister to transfer COVID-19 tests and instruments used in relation to those tests to the provinces and territories and to bodies and persons in Canada.

Government Business No. 8—Proceedings on Bill C-10

[Damien Kurek, Conservative, Battle River—Crowfoot, AB]

Mr. Speaker, I have made a number of observations, both in my speech and in a few of the questions and comments. This would have been a great conversation to have had in September of last year. Unfortunately, the Liberal Prime Minister made a very clear and direct choice to ignore what I think was in the best interests of Canadians and plunged the country into an election during the fourth wave of what is a pandemic.

Specifically, we are talking about rapid tests. There is widespread agreement about that being an important tool in the tool belt in the fight against COVID-19. I am very curious if the member has any thoughts on how, after the Minister of Health criticized Conservatives for asking questions about standardizing border testing, arrival testing with other like-minded jurisdictions, he seemed to indicate the other day that the government would in fact be moving in that direction.

Could the member answer for his health minister's hypocrisy on that matter?

[Peter Fragiskatos, Liberal, London North Centre, ON]

Mr. Speaker, first of all, words like “hypocrisy” have to be used very carefully, if at all, in this House. I think it is important to maintain basic decorum. I do not know the member very well, but I would hope he would live up to the honour of the office that he holds.

The health minister is doing exactly as we would hope. He is looking at the science and listening to the health experts. On the specific matter of what is happening at the border, our policy evolves. It evolves because as the pandemic evolves, so too does policy. That is something that has been clear throughout the pandemic. At every step the government has consulted with health experts before putting policy in place.

I wish that some in this House would believe in science, listen to it and listen to the health experts. We would be in much more agreement if that were the case.

[Richard Cannings, NDP, South Okanagan—West Kootenay, BC]

Mr. Speaker, I would like to thank the member for mentioning health care workers. As we all know, they have been at the forefront, the pointy end of the stick, as far as COVID goes in terms of both their physical health and mental health risks.

Another sector that has really been impacted by COVID is tourism. Two years after COVID began, the government still is not getting the supports right for many tourism operators. Independent contractors of any sort, including independent travel advisers, are not able to access any supports. New businesses that started up just as COVID was starting up are still unable to access the supports that all of their competitors have.

I am wondering this. Can the member comment on why the government seems to be blind to all of these needs?

[Peter Fragiskatos, Liberal, London North Centre, ON]

Mr. Speaker, I thank the member for his service. I do not know him that well, but I have always known him to be someone who cares very sincerely about the work and who has done a great deal for his constituents.

On this matter, we will disagree a bit. If we look at what the federal government has done since the onset of the pandemic, it responded very swiftly. It made historic efforts to put in place policy to deal with what is, I think we can all agree, the most difficult situation that has faced this country since the Second World War. Whether it is tourism operators or small or large businesses, we will continue to be there for Canadians as we have been throughout the pandemic, putting in place a number of measures, economic and otherwise, to meet the challenges head-on.

In my own community of London, we have been there whether for tourism operators or others. There is more we can do, of course, and we can look at that, but when it is all said and done, historians will have a lot to say on what has happened, and we will have favourable judgments in the years to come.

[Ya'ara Saks, Liberal, Parliamentary Secretary to the Minister of Families]

Mr. Speaker, I am pleased to rise today to speak about Bill C-10, an act respecting certain measures related to COVID-19, and how the federal government is working to ensure that Canada continues to have a sufficient supply of COVID‑19 rapid tests.

I would like to thank my colleague, the member for London North Centre, for his previous comments. I have heard colleagues throughout the House speak tonight about many other issues. However, I would like to focus my comments this evening on the bill itself, which is known as Bill C-10.

Unfortunately, COVID continues to have a significant impact on the lives of Canadians and remains an unparalleled threat to the health, social and economic well-being of Canadians. As public health restrictions ease in some jurisdictions, testing and the availability of rapid tests will take on an even higher level of importance in our fight against COVID‑19.

Ensuring that all Canadians have what they need to be safe during this critical time is a responsibility that our government takes very seriously. Since the outset of the pandemic, the Government of Canada has worked closely with provinces and territories, taking a team Canada approach to responding to the pandemic. I would like to begin my remarks today by briefly highlighting some of the key initiatives our government has taken thus far to protect Canadians and to help our country recover.

From the very beginning of the pandemic, the Government of Canada was committed to working closely with all levels of government to put the health and safety of Canadians first. The safe restart agreement was a significant element of this team Canada approach. It led to the direct transfer of $3 billion to provinces and territories to enhance testing, contact tracing and data management, with additional monies made available by the Government of Canada to procure COVID‑19 PCR tests. Thanks to the funding from the safe restart agreement, health units across Canada have been able to better identify who was infected, where that person was infected and how much the virus was circulating in communities.

As the pandemic has changed, so has the need for testing. Today, rapid tests are a more important tool in the government's arsenal than ever before. Our government has worked tirelessly, as we have throughout the past two years, in collaboration with provinces and territories to expedite the delivery of rapid tests from coast to coast to coast.

Rapid tests are safe. They are effective. They are easy to administer, and they provide quick results. Their availability empowers Canadians to make informed decisions to protect their health and the health of their loved ones and to avoid spreading the virus further. Since the onset of the COVID‑19 pandemic, all levels of government have collaborated with experts to ensure they have the best evidence, and the best science, to make informed decisions on COVID‑19 testing and screening.

In November, 2020, the Minister of Health formally established the COVID-19 testing and screening expert advisory panel. The panel provided science and policy advice to help inform decisions on innovative approaches to COVID‑19 testing and screening, including advice on the best use of tests, strategies for different settings, and emerging technologies, again following the science.

The panel consisted of highly respected professionals with a broad range of expertise in areas such as health policy, infectious diseases and the implementation of public health measures. Over the course of nine months, the expert panel published five reports, including, “Priority strategies to optimize self-testing in Canada”, which was published in August, 2021. This report provided the foundation by which provinces and territories expanded their testing programs.

Combatting COVID‑19 is about collaboration between the Public Health Agency of Canada and Health Canada, complemented by the work of an expert advisory panel. This collaboration includes the release of updated pan-Canadian COVID‑19 testing and screening guidance, and a white paper on testing for COVID‑19 in vaccinated populations. These references underscore the importance of continued testing, especially to protect vulnerable populations, and the need for all jurisdictions to sustain COVID‑19 rapid test stockpiles for surge testing to minimize and respond quickly to outbreaks.

Getting Canadians through this pandemic did not only require collaboration among all levels of government, but also required innovative partnerships with the private sector. That is why the government also established innovative partnerships with the establishment of an industry advisory round table on COVID‑19 testing, screening, tracing and data management with members from large, critical industries.

This collaboration led to the launch of the Creative Destruction Lab Rapid Screening Consortium: a non-profit organization located at the University of Toronto, initially comprising 12 companies with national operations. The consortium aimed to develop a system capable of conducting COVID‑19 screening that could produce results within 15 minutes. Let us think about that: in only 15 minutes, we could have an answer to protect our loved ones.

In April, 2021, through the safe restart agreement, Health Canada funded the consortium to expand its program to support the rollout of rapid screening pilots for asymptomatic employees across Canada. As of January 26, 2022, Creative Destruction Lab Rapid Screening Consortium had already onboarded over 2,000 organizations from coast to coast to coast, including school boards, child care centres, long-term care facilities and an array of businesses such as airlines, couriers, banks, mines and retail settings. It was essentially every part of Canada that it could get to.

Additionally, the Canadian Red Cross has been an important partner, providing surge support to provinces and territories for direct patient care. Complementing the work of the consortium, the government partnered with the Canadian Red Cross to support testing and screening in the non-profit sector. In 2021, approximately 300,000 tests were provided to the Canadian Red Cross for this initiative. Through this innovative partnership, 234 non-profit organizations across the country have launched testing programs, receiving support, guidance and test kits directly from the Red Cross. Over 1.6 million tests have been distributed so far through this initiative.

I would like to talk about our northern, remote and isolated communities program. In response to the COVID-19 pandemic, and in the spirit of truth and reconciliation, the northern, remote and isolated communities initiative was established in early 2020 to ensure equitable access to health care for people living in northern, remote and isolated, NRI, communities across Canada. This initiative prioritizes distribution of point-of-care diagnostic testing supplies, including molecular tests, to communities and to the homes of many first nations, Métis and Inuit peoples. Led by the Public Health Agency of Canada's National Microbiology Laboratory, and in collaboration with Indigenous Services Canada, the program has included training for the installation and use of COVID-19 tests.

To date, the National Microbiology Laboratory has provided more than 230 training sessions for non-health-care professionals to implement point-of-care testing in NRI communities. As of January 16, 2022, over and above the supply provided to provinces and territories, a total of 651 testing instruments and 1,196,039 tests had been deployed to support testing in more than 300 NRI communities.

In conclusion, we have done much as a country to fight this pandemic, and Canadians should feel encouraged by the progress we have made, but it is without question that the months ahead of us will continue to be full of challenges and that we need to do even more to support our country. I ask all of my colleagues to join me and those of us on this side of the floor in supporting the adoption of this bill, so that we can continue to provide critical and timely support to provinces, territories, workplaces and Canadians through this ongoing procurement process and timely distribution of COVID-19 rapid tests that will help keep us all safe.

[Stephen Ellis, Conservative, Cumberland—Colchester, NS]

Mr. Speaker, the member opposite mentioned a lot of numbers and a lot of supports about all these tests that have been done and all these interesting organizations. It is interesting. Just because something is numerous and noisy does not make it right, and I think that is an important thing we should all consider.

That being said, I need to make something clear. In asymptomatic people who use rapid antigen tests, the sensitivity is about 44% in some studies, which would mean massive numbers of people actually have COVID who are told they do not. The math is simple: 44% of people would say they have COVID, but there would be a whole bunch of people who we would have missed.

Again, if these things are as important as the science these Liberals keep talking about, would it not make sense to simply send this bill to the health committee to be studied before we pass it?

[Ya'ara Saks, Liberal, York Centre, ON]

Mr. Speaker, the member is a physician, so I think he would appreciate the science that goes with this and understand that all of this work and all of this testing and research and discussions and consortiums and collaboration between the private and public sector and science has been the reason we have gotten this far in the pandemic in protecting Canadians. The tests help protect our loved ones. These tests are an important tool that have shown time and again how we can control the spread of COVID-19.

To remind my colleague, at the beginning of the pandemic, his side of the aisle, and this was before I was a member of the House, screamed for tests, demanded tests and wanted nothing more than for us to get more tests. At the time, the tests were not all that accurate and that is why we did the work with the consortium, with science and with researchers to improve the quality of testing in this country so that as we move forward now through omicron we have the tools and we have the capability of keeping our population safe as we start to move through this phase of the pandemic.

[Alistair MacGregor, NDP, Cowichan—Malahat—Langford, BC]

Mr. Speaker, I know we in the House and indeed every Canadian feel like we have been running a marathon and the last thing we want to do right now is stumble at the last 100 metres. It is really important during these heightened tensions we are feeling over the last couple of weeks to remember that there are still a significant number of Canadians who are at risk from COVID-19, who have loved ones who are in the hospitals and some who are in the ICU.

I am wondering if my hon. colleague could offer some comments on that. We are not out of the woods yet with COVID-19. We may be able to see the finish line, but it is important that we stay focused to make sure that we come out on the right side of this.

[Ya'ara Saks, Liberal, York Centre, ON]

Mr. Speaker, I would like to thank my hon. colleague from British Columbia. It is where much of my family lives and I miss them terribly.

I am tired. My kids are tired. Many members of the House are tired, but the truth is that our ICUs are still struggling with the numbers. We are seeing the cases stabilize a little, but the reality is that we have many Canadians who are immunocompromised, who have other vulnerabilities and who need tools to move forward safely.

A constituent in my riding is a kidney transplant recipient. He cannot go outside. He is waiting for more tests so that he can move on with his life. I hope the members of the House understand that the science and the tools that we need to move forward for Canadians include the procurement and distribution of rapid tests equitably, safely and fairly for every Canadian who needs them.

[Marc Dalton, Conservative, Pitt Meadows—Maple Ridge, BC]

Mr. Speaker, it is good to be here this evening in this debate discussing our amendment.

The Conservative Party brought forward this amendment because we feel there just needs to be more time to examine the bill. There is no rush to bring it forward. It has to go through the Senate, which is not even sitting until next week. We need to be able to examine it. We need the minister to come here so that we can ask questions. I have a few minutes to give some of the reasons why we need to ask some questions. We are supportive of bringing rapid tests to Canadians but there are some serious issues that we need to address here this evening.

This is par for the course. It is freezing outside right now in Ottawa, but we may as well be playing golf for the Liberals because it is par for the course. I think back to two years ago when Conservatives brought forward concerns about what was happening in China, Italy and Iran. We brought forward these things. What were we accused of? We were accused of being racists. That is language they love to use, “You're a racist,” and we were just bringing forward some concerns. They always seem to be behind in the game. Speaking of games, it took the NHL and the NBA to cancel their seasons before they realized they had better do something more serious.

The government likes to convince Canadians that their actions related to the pandemic are done only with their best interests in mind. That really causes me and many others to scratch our heads and wonder if it's really in Canadians' best interests or if it is in their close friends' interests, their polling numbers or whether they can get gold, silver and bronze in sharing some of the benefits among those who are close to them. The facts speak for themselves. As a case in point, we had Mr. Frank Baylor, or “Frankie”. Liberals should know him. He was an MP until 2018—

[Elizabeth May, Green, Saanich—Gulf Islands, BC]

Mr. Speaker, on a point of order, I am sure the hon. member would not want to misname our former colleague, Frank Baylis, who led a charge here for greater democracy in the House.

[The Speaker, Liberal, Anthony Rota]

I want to thank the hon. member for getting up.

We will let the hon. member continue.

[Marc Dalton, Conservative, Pitt Meadows—Maple Ridge, BC]

Mr. Speaker, MP Frank Baylis got a contract. He definitely had the inside track for ventilators, for a company that had not built them. He had never made ventilators before. It was a sole-purpose contract for $236 million. It had never been tested or used before. They charged twice its value compared to the competition. It is emergency funding. Therefore, let us give it to our buddies. That is what we see with the Liberals. Just ask Jody Wilson-Raybould what is going on here. It is the same old, same old on that side.

What other sorts of things would cause us maybe to want to look a bit more into their expenditures? How about the WE scandal? What exactly was the WE scandal? Get an organization working with children and do you know what? Maybe a million dollars approximately was given to the Prime Minister's brother, mother and family for speaking fees. What did they get? They got a three-quarters of a billion-dollar contract for something—

[The Speaker, Liberal, Anthony Rota]

The hon. Minister of Northern Affairs.

[Dan Vandal, Liberal, Saint Boniface—Saint Vital, MB]

Mr. Speaker, what the member is talking about has nothing to do with the topic at hand of securing rapid tests for Canadians. I know in my province of Manitoba rapid tests are severely needed. Manitobans need them, so could the hon. member get back to the topic at hand?